New nerve ablation procedure targets low back pain: 5 observations on the alterative treatment

Spine

Royal Oak, Mich.-based Beaumont Hospital researchers are conducting the Relievant SMART trial. The recently FDA-cleared clinical study is testing the efficacy of a minimally invasive nerve ablating procedure, according to News-Medical.

The study involves 150 patients receiving the minimally invasive nerve ablating procedure and 75 receiving the placebo.

 

Here are five observations:

 

1. The procedure involves using radio frequency energy to target the nerve causing the low back pain.

 

2. Surgeons insert an access tube through a small cut in a patient's back, toward a vertebral body. Then, they transmit radiofrequency energy via the device.

 

3. Surgeons perform the procedure in less than one hour.

 

4. The researchers found those patients receiving the nerve ablating procedure reported "significant improvement in their back pain within two weeks of surgery," according to News-Medical.

 

5. Redwood City, Calif.-based Relievant Medsystems developed the nerve ablating procedure.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers